ADCY5 screening in paediatric-onset hyperkinetic movement disorders: Report of three new Italian families
Objective: To report three new cases with pathogenic ADCY5 mutations and describe their clinical phenotype. Background: ADCY5 is a recently identified gene responsible for a…Gait and anthropometric characteristics of patients with Parkinson’s disease seen in a Nigerian tertiary hospital
Objective: To assess selected gait and anthropometric parameters in patients with Parkinson's disease atteding the Physical therapy clinic of the Obafemi Awolowo Univeersity Teaching Hospitals…Predicting risk of sarcopenia in people with Parkinson’s disease
Objective: This study aimed to evaluate the risk of sarcopenia in Parkinson's disease (PD) community residents according a screening by using motor performance tests. Background:…CSF level of chromogranin A in amyotrophic lateral sclerosis
Objective: Today the diagnosis of amyotrophic lateral sclerosis (ALS) is based on clinical assessment of upper and lower motor neuron signs in the limb and/or…European physiotherapy guideline for Parkinson’s disease: Information for neurologists
Objective: We aim to inform physicians on the value of physiotherapy (PT) for people with Parkinson's disease (PwP) and on opportunities to optimize referral to…A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery
Objective: To improve our understanding of the pathophysiology and etiology of hemifacial spasm (HFS). Background: HFS is involuntary unilateral contractions of the muscles innervated by…Combinative therapy of memantine and galantamine hydrobromide as a tool of choice for the treatment of vascular parkinsonism with early appearance of dementia symptoms
Objective: Our primary aim was comparative study of monotherapy with memantine and combinative therapy with memantine and galantamine hydrobromide for treatment of vascular parkinsonism with…Targeting PDE7 by the small molecule S14: A potential disease-modifying Parkinson�s disease therapy ready to start clinical trials
Objective: The main goal of this work is the regulatory chemical, pharmaceutical and toxicological development of S14, a new therapeutic class for the potential treatment…A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson’s disease: The INVEST study
Objective: To compare costs and effectiveness of the therapies DBS and CLI in advanced PD. Background: The therapies deep brain stimulation (DBS) and continuous intrajejunale…Does distance walked after two minutes predict total 6 minute walk test distance in people with Parkinson’s disease?
Objective: To determine if the distance walked in the first two minutes of the 6 Minute Walk Test (6MWT) accurately predicts the total distance walked…
- « Previous Page
- 1
- …
- 179
- 180
- 181
- 182
- 183
- …
- 207
- Next Page »